NARDONE, VALERIO
NARDONE, VALERIO
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures
2018-01-01 Nardone, Valerio; Tini, Paolo; Croci, Stefania; Carbone, Salvatore Francesco; Sebaste, Lucio; Carfagno, Tommaso; Battaglia, Giuseppe; Pastina, Pierpaolo; Rubino, Giovanni; Mazzei, Maria Antonietta; Pirtoli, Luigi
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
2017-01-01 Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk.
2016-01-01 Nardone, Valerio; Tini, Paolo; Sebaste, Lucio; Biondi, Michelangelo; BANCI BUONAMICI, Fabrizio; Pirtoli, Luigi
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures.
2017-01-01 Nardone, Valerio; Tini, Paolo; Carbone, SALVATORE FRANCESCO; Grassi, Andrea; Biondi, Michelangelo; Sebaste, Lucio; Carfagno, Tommaso; Vanzi, Eleonora; De Otto, G; Battaglia, Giuseppe; Rubino, G; Pastina, Pierpaolo; Belmonte, Giuseppe; Mazzoni, Ln; BANCI BUONAMICI, Fabrizio; Mazzei, MARIA ANTONIETTA; Pirtoli, L.
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma
2015-01-01 Tini, Paolo; Belmonte, Giuseppe; Toscano, Marzia; Miracco, Clelia; Palumbo, Silvia; Pastina, Pierpaolo; Battaglia, Giuseppe; Nardone, Valerio; Butorano, MARIE AIMEE GLORIA MUNEZERO; Masucci, Armando; Cerase, Alfonso; Pirtoli, Luigi
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma?
2022-01-01 Correale, P; Pentimalli, F; Nardone, V; Giordano, A; Mutti, L
Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer)
2021-01-01 Mazzei, Maria Antonietta; Di Giacomo, Letizia; Bagnacci, Giulio; Nardone, Valerio; Gentili, Francesco; Lucii, Gabriele; Tini, Paolo; Marrelli, Daniele; Morgagni, Paolo; Mura, Gianni; Baiocchi, Gian Luca; Pittiani, Frida; Volterrani, Luca; Roviello, Franco
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide.
2018-01-01 Tini, P; Nardone, V; Pastina, P; Battaglia, G; Miracco, C; Carbone, Sf; Sebaste, L; Rubino, G; Cerase, A; Pirtoli, L.
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up
2019-01-01 Caraglia, M.; Correale, P.; Giannicola, R.; Staropoli, N.; Botta, C.; Pastina, P.; Nesci, A.; Caporlingua, N.; Francini, E.; Ridolfi, L.; Mini, E.; Roviello, G.; Ciliberto, D.; Agostino, R. M.; Strangio, A.; Azzarello, D.; Nardone, V.; Falzea, A.; Cappabianca, S.; Bocchetti, M.; D'Arrigo, G.; Tripepi, G.; Tassone, P.; Addeo, R.; Giordano, A.; Pirtoli, L.; Francini, G.; Tagliaferri, P.
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
2020-01-01 Correale, P.; Saladino, R. E.; Giannarelli, D.; Sergi, A.; Mazzei, M. A.; Bianco, G.; Giannicola, R.; Iuliano, E.; Forte, I. M.; Calandruccio, N. D.; Falzea, A. C.; Strangio, A.; Nardone, V.; Pastina, P.; Tini, P.; Luce, A.; Caraglia, M.; Caracciolo, D.; Mutti, L.; Tassone, P.; Pirtoli, L.; Giordano, A.; Tagliaferri, P.
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program
2016-01-01 Correale, P; Botta, C; Martino, Ec; Nardone, V; Ulivieri, C; Gandolfo, C; Baldari, Tc; Lazzi, S; Ginori, A; Fioravanti, A; Guidelli, Gm; Pirtoli, L; Giordano, A; Tassone, P; Tagliaferri, P; Cusi, Mg
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab
2017-01-01 Pastina, Pierpaolo; Nardone, Valerio; Battaglia, Giuseppe; Botta, Cirino; Tini, Paolo; Bellan, Cristiana; Ricci, Veronica; Barbarino, Marcella; Croci, Stefania; Caraglia, Michele; Giordano, Antonio; Cusi, MARIA GRAZIA; Pirtoli, Luigi; Pierpaolo, Correale
In Regard to Kubicek et al.
2016-01-01 Tini, Paolo; Nardone, Valerio; Pastina, Pierpaolo; Battaglia, Giuseppe; Sebaste, Lucio; Pirtoli, Luigi
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy
2015-01-01 Carfagno, T; Semeraro, L; Nardone, V; Vischi, G; Ferrara, P; Ambrosio, M; Barone, A; Martino, E; Pastina, P; Pirtoli, L; Correale, P
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?
2019-01-01 Tini, P.; Nardone, V.; Pastina, P.; Marampon, F.; Sebaste, L.; Cerase, A.; Tombolini, V.; Pirtoli, L.; Mazzei, M. A.
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma?
2017-01-01 Tini, Paolo; Nardone, Valerio; Pirtoli, Luigi
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation
2019-01-01 Nardone, V.; Reginelli, A.; Scala, F.; Carbone, S. F.; Mazzei, M. A.; Sebaste, L.; Carfagno, T.; Battaglia, G.; Pastina, P.; Correale, P.; Tini, P.; Pellino, G.; Cappabianca, S.; Pirtoli, L.
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy
2017-01-01 Tini, Paolo; Nardone, Valerio; Pastina, Pierpaolo; Battaglia, Giuseppe; Miracco, Clelia; Sebaste, Lucio; Rubino, Giovanni; Cerase, Alfonso; Pirtoli, Luigi
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach
2022-01-01 Fameli, Antonella; Nardone, Valerio; Shekarkar Azgomi, Mojtaba; Bianco, Giovanna; Gandolfo, Claudia; Oliva, Bianca Maria; Monoriti, Marika; Saladino, Rita Emilena; Falzea, Antonella; Romeo, Caterina; Calandruccio, Natale Daniele; Azzarello, Domenico; Giannicola, Rocco; Pirtoli, Luigi; Giordano, Antonio; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Mutti, Luciano; Botta, Cirino; Correale, Pierpaolo
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis
2020-01-01 Vinciguerra, C.; Giorgio, A.; Zhang, J.; Nardone, V.; Tappa Brocci, R.; Pasto, L.; Niccolai, C.; Stromillo, M. L.; Mortilla, M.; Amato, M. P.; De Stefano, N.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| 3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures | 1-gen-2018 | Nardone, Valerio; Tini, Paolo; Croci, Stefania; Carbone, Salvatore Francesco; Sebaste, Lucio; Carfagno, Tommaso; Battaglia, Giuseppe; Pastina, Pierpaolo; Rubino, Giovanni; Mazzei, Maria Antonietta; Pirtoli, Luigi | - | |
| Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients | 1-gen-2017 | Pastina, Pierpaolo; Nardone, Valerio; Croci, Stefania; Battaglia, Giuseppe; Vanni, Francesca; Bellan, Cristiana; Barbarino, Marcella; Ricci, Veronica; Costantini, Susan; Capone, Francesca; Botta, Cirino; Zarone, Mayra Rachele; Misso, Gabriella; Boccellino, Mariarosaria; Caraglia, Michele; Giordano, Antonio; Paladini, Piero; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Pirtoli, Luigi; Correale, Pierpaolo | - | |
| Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. | 1-gen-2016 | Nardone, Valerio; Tini, Paolo; Sebaste, Lucio; Biondi, Michelangelo; BANCI BUONAMICI, Fabrizio; Pirtoli, Luigi | - | |
| Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. | 1-gen-2017 | Nardone, Valerio; Tini, Paolo; Carbone, SALVATORE FRANCESCO; Grassi, Andrea; Biondi, Michelangelo; Sebaste, Lucio; Carfagno, Tommaso; Vanzi, Eleonora; De Otto, G; Battaglia, Giuseppe; Rubino, G; Pastina, Pierpaolo; Belmonte, Giuseppe; Mazzoni, Ln; BANCI BUONAMICI, Fabrizio; Mazzei, MARIA ANTONIETTA; Pirtoli, L. | - | |
| Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma | 1-gen-2015 | Tini, Paolo; Belmonte, Giuseppe; Toscano, Marzia; Miracco, Clelia; Palumbo, Silvia; Pastina, Pierpaolo; Battaglia, Giuseppe; Nardone, Valerio; Butorano, MARIE AIMEE GLORIA MUNEZERO; Masucci, Armando; Cerase, Alfonso; Pirtoli, Luigi | - | |
| CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? | 1-gen-2022 | Correale, P; Pentimalli, F; Nardone, V; Giordano, A; Mutti, L | - | |
| Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer) | 1-gen-2021 | Mazzei, Maria Antonietta; Di Giacomo, Letizia; Bagnacci, Giulio; Nardone, Valerio; Gentili, Francesco; Lucii, Gabriele; Tini, Paolo; Marrelli, Daniele; Morgagni, Paolo; Mura, Gianni; Baiocchi, Gian Luca; Pittiani, Frida; Volterrani, Luca; Roviello, Franco | - | |
| Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. | 1-gen-2018 | Tini, P; Nardone, V; Pastina, P; Battaglia, G; Miracco, C; Carbone, Sf; Sebaste, L; Rubino, G; Cerase, A; Pirtoli, L. | - | |
| GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up | 1-gen-2019 | Caraglia, M.; Correale, P.; Giannicola, R.; Staropoli, N.; Botta, C.; Pastina, P.; Nesci, A.; Caporlingua, N.; Francini, E.; Ridolfi, L.; Mini, E.; Roviello, G.; Ciliberto, D.; Agostino, R. M.; Strangio, A.; Azzarello, D.; Nardone, V.; Falzea, A.; Cappabianca, S.; Bocchetti, M.; D'Arrigo, G.; Tripepi, G.; Tassone, P.; Addeo, R.; Giordano, A.; Pirtoli, L.; Francini, G.; Tagliaferri, P. | - | |
| HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis | 1-gen-2020 | Correale, P.; Saladino, R. E.; Giannarelli, D.; Sergi, A.; Mazzei, M. A.; Bianco, G.; Giannicola, R.; Iuliano, E.; Forte, I. M.; Calandruccio, N. D.; Falzea, A. C.; Strangio, A.; Nardone, V.; Pastina, P.; Tini, P.; Luce, A.; Caraglia, M.; Caracciolo, D.; Mutti, L.; Tassone, P.; Pirtoli, L.; Giordano, A.; Tagliaferri, P. | - | |
| Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program | 1-gen-2016 | Correale, P; Botta, C; Martino, Ec; Nardone, V; Ulivieri, C; Gandolfo, C; Baldari, Tc; Lazzi, S; Ginori, A; Fioravanti, A; Guidelli, Gm; Pirtoli, L; Giordano, A; Tassone, P; Tagliaferri, P; Cusi, Mg | - | |
| Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab | 1-gen-2017 | Pastina, Pierpaolo; Nardone, Valerio; Battaglia, Giuseppe; Botta, Cirino; Tini, Paolo; Bellan, Cristiana; Ricci, Veronica; Barbarino, Marcella; Croci, Stefania; Caraglia, Michele; Giordano, Antonio; Cusi, MARIA GRAZIA; Pirtoli, Luigi; Pierpaolo, Correale | - | |
| In Regard to Kubicek et al. | 1-gen-2016 | Tini, Paolo; Nardone, Valerio; Pastina, Pierpaolo; Battaglia, Giuseppe; Sebaste, Lucio; Pirtoli, Luigi | - | |
| Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy | 1-gen-2015 | Carfagno, T; Semeraro, L; Nardone, V; Vischi, G; Ferrara, P; Ambrosio, M; Barone, A; Martino, E; Pastina, P; Pirtoli, L; Correale, P | - | |
| Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? | 1-gen-2019 | Tini, P.; Nardone, V.; Pastina, P.; Marampon, F.; Sebaste, L.; Cerase, A.; Tombolini, V.; Pirtoli, L.; Mazzei, M. A. | - | |
| Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? | 1-gen-2017 | Tini, Paolo; Nardone, Valerio; Pirtoli, Luigi | - | |
| Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation | 1-gen-2019 | Nardone, V.; Reginelli, A.; Scala, F.; Carbone, S. F.; Mazzei, M. A.; Sebaste, L.; Carfagno, T.; Battaglia, G.; Pastina, P.; Correale, P.; Tini, P.; Pellino, G.; Cappabianca, S.; Pirtoli, L. | - | |
| Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy | 1-gen-2017 | Tini, Paolo; Nardone, Valerio; Pastina, Pierpaolo; Battaglia, Giuseppe; Miracco, Clelia; Sebaste, Lucio; Rubino, Giovanni; Cerase, Alfonso; Pirtoli, Luigi | - | |
| PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach | 1-gen-2022 | Fameli, Antonella; Nardone, Valerio; Shekarkar Azgomi, Mojtaba; Bianco, Giovanna; Gandolfo, Claudia; Oliva, Bianca Maria; Monoriti, Marika; Saladino, Rita Emilena; Falzea, Antonella; Romeo, Caterina; Calandruccio, Natale Daniele; Azzarello, Domenico; Giannicola, Rocco; Pirtoli, Luigi; Giordano, Antonio; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; Cusi, Maria Grazia; Mutti, Luciano; Botta, Cirino; Correale, Pierpaolo | - | |
| Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis | 1-gen-2020 | Vinciguerra, C.; Giorgio, A.; Zhang, J.; Nardone, V.; Tappa Brocci, R.; Pasto, L.; Niccolai, C.; Stromillo, M. L.; Mortilla, M.; Amato, M. P.; De Stefano, N. | - |